Kalyan Jewellers India Ltd

₹ 116 5.24%
05 Dec 4:01 p.m.
About

Kalyan Jewellers India Ltd. designs manufacture and sells a range of gold, studded and other jewellery products across various price points. It is one of the largest jewellery retailers in India based on revenue as of FY20. The co. was founded by the current Chairman, MD and Promoter, Mr T.S. Kalyanaraman [1]

Key Points

Market Share as of FY20
Overall Jewellery Market: 2%
Organized Jewellery Market: 6% [1] [2]

  • Market Cap 11,903 Cr.
  • Current Price 116
  • High / Low 116 / 55.0
  • Stock P/E 28.3
  • Book Value 32.2
  • Dividend Yield 0.00 %
  • ROCE 9.36 %
  • ROE 7.51 %
  • Face Value 10.0

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 3.59 times its book value
  • Company has a low return on equity of 4.75% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
2,141 782 1,798 2,936 3,057 1,637 2,889 3,435 2,857 3,333 3,473
1,961 722 1,780 2,648 2,829 1,568 2,661 3,136 2,639 3,068 3,207
Operating Profit 180 60 18 288 228 69 228 299 218 264 266
OPM % 8% 8% 1% 10% 7% 4% 8% 9% 8% 8% 8%
40 13 13 7 12 5 5 17 11 8 8
Interest 93 91 99 99 87 81 84 82 76 71 74
Depreciation 60 60 56 55 55 58 57 59 58 59 60
Profit before tax 67 -77 -123 142 98 -65 92 176 96 142 140
Tax % 28% -11% -10% 18% 25% 21% 25% 23% 25% 24% 25%
Net Profit 48 -86 -136 115 74 -51 69 135 72 108 106
EPS in Rs 0.72 -0.50 0.67 1.31 0.70 1.05 1.03
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
10,505 9,771 10,101 8,573 10,818 13,098
9,732 9,151 9,302 7,949 9,965 12,050
Operating Profit 774 620 799 624 853 1,048
OPM % 7% 6% 8% 7% 8% 8%
32 42 80 45 38 45
Interest 390 418 419 405 360 303
Depreciation 202 224 239 225 232 236
Profit before tax 214 21 221 39 299 554
Tax % 34% 123% 36% 115% 25%
Net Profit 141 -5 142 -6 224 420
EPS in Rs -0.06 2.18 4.09
Dividend Payout % -0% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 3%
TTM: 25%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 294%
TTM: 104%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 67%
Return on Equity
10 Years: %
5 Years: %
3 Years: 5%
Last Year: 8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
958 958 958 1,030 1,030 1,030
Reserves 1,012 1,046 1,203 1,796 2,107 2,282
4,077 3,788 3,640 4,081 4,029 4,005
2,622 2,387 2,536 1,958 1,779 2,383
Total Liabilities 8,551 8,060 8,219 8,865 8,945 9,700
1,879 2,152 2,167 1,899 1,921 1,978
CWIP 18 22 24 53 2 2
Investments 1 3 -0 -0 1 3
6,654 5,884 6,027 6,913 7,021 7,717
Total Assets 8,551 8,060 8,219 8,865 8,945 9,700

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
320 629 245
34 -217 64
-343 -208 -524
Net Cash Flow 11 204 -216

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 6 5 8 5 4
Inventory Days 208 200 205 272 232
Days Payable 31 19 24 35 26
Cash Conversion Cycle 184 187 189 241 210
Working Capital Days 121 123 122 157 146
ROCE % 7% 11% 7% 9%

Shareholding Pattern

Numbers in percentages

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
60.53 60.53 60.54 60.54 60.54 60.54 60.54
4.80 4.04 2.87 3.26 3.05 2.77 2.75
1.67 1.62 1.89 2.07 1.74 1.96 2.58
33.00 33.81 34.70 34.13 34.67 34.73 34.14

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents